tert-Butyl isocyanate → HCID 178478853, 화합물

HRID 2083369노트

반응식

HRID 2083369 반응식
C([N:5]=C=[O:7])(C)(C)C.O.[NH2:9][C:10]1[C:11]([C:18]([N:20]=[CH:21][NH:22]NC(NC(C)(C)C)=O)=[O:19])=[N:12][C:13]([Cl:17])=[C:14]([NH2:16])[N:15]=1.[NH2:31][C:32]1[C:33]([C:40]([N:42]=[CH:43][NH:44][NH:45][C:46]([NH:48]C(C)(C)C)=[O:47])=[O:41])=[N:34][C:35]([Cl:39])=[C:36]([NH2:38])[N:37]=1>>[OH2:7].[ClH:17].[NH2:31][C:32]1[C:33]([C:40]([N:42]=[C:43]([NH:44][C:18]([NH2:20])=[O:19])[NH2:5])=[O:41])=[N:34][C:35]([Cl:39])=[C:36]([NH2:38])[N:37]=1.[NH2:9][C:10]1[C:11]([C:18]([N:20]=[C:21]([NH2:22])[NH:45][C:46]([NH2:48])=[O:47])=[O:19])=[N:12][C:13]([Cl:17])=[C:14]([NH2:16])[N:15]=1.[ClH:17]

참가 물질

3

반응물 2

HCID 62412tert-Butyl isocyanateHCID 178449604HCID 178449604, 화합물

생성물 1

HCID 178478853HCID 178478853, 화합물

실험 절차

Following the procedure of Example 23, Steps A and B but using the following pyrazinecarboxamides in place of the pyrazinecarboxamide used in Example 23, Step A, but using an equivalent amount of t-butylisocyanate and then following the procedure of Example 23B but using the appropriate pyrazinecarboxamide from Step A of that example the appropriate end product as listed is obtained.

후처리

  1. customas listed is obtained

출처 및 근거

ORD 기록
ord-870047f1e2e14aee8ae45d3d10ff0aa8
출처 데이터셋
uspto-grants-1978_04
특허 번호
US04085211

반응 노트

불러오는 중…